Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
Loading GLMD News...
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| VRX | Valeant Pharmaceuticals International, Inc. | 1.84% | 14.16 | 14.2% | $222.36m | |
| SHPG | Shire PLC Sponsored ADR | 0.49% | 148.44 | 0.4% | $213.37m | |
| PRGO | Perrigo Co. Plc | 1.84% | 79.20 | 6.4% | $155.33m | |
| MNK | Mallinckrodt Plc | 0.87% | 35.94 | 17.7% | $115.49m | |
| UTHR | United Therapeutics Corporation | 1.76% | 132.04 | 13.9% | $88.84m | |
| ALR | Alere Inc. | 0.22% | 49.60 | 2.7% | $76.96m | |
| JAZZ | Jazz Pharmaceuticals Plc | 0.53% | 147.40 | 2.2% | $71.01m | |
| ENDP | Endo International Plc | 6.88% | 8.70 | 8.9% | $67.71m | |
| PRXL | PAREXEL International Corporation | 0.05% | 87.76 | 7.9% | $66.28m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 1.33% | 105.47 | 22.1% | $62.18m | |
| HZNP | Horizon Pharma plc | -0.42% | 11.89 | 7.6% | $53.22m | |
| MYOK | MyoKardia, Inc. | 5.69% | 42.70 | 3.0% | $47.24m | |
| NDRM | NeuroDerm Ltd. | 0.13% | 38.65 | 3.6% | $46.13m | |
| PTLA | Portola Pharmaceuticals, Inc. | -0.56% | 54.70 | 8.9% | $44.17m | |
| MDCO | Medicines Company | 0.19% | 36.66 | 22.3% | $43.14m |
Company Profile
Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of Aramchol, a novel, once-daily, oral therapy for treating liver diseases utilizing its proprietary first-in-class family of synthetic fatty-acid/bile-acid conjugates, or FABACs. The Aramchol is initially being developed for treating Non-Alcoholic Steato-hepatitis, or NASH, a chronic disease affecting a large population, for treating patients who also suffer from obesity and insulin resistance. The company was founded by Allen Baharaff and Tuvia Gilat in 2000 and is headquartered in Tel Aviv, Israel.